When Does Rexulti Go Generic?
The patent exclusivity for Rexulti (brexpiprazole) is scheduled to expire in 2027 [1]. Following this expiration, generic versions of the drug may become available, potentially leading to lower prices.
What Happens After Patent Expiry?
Once patent protection ends, other pharmaceutical companies can seek approval to manufacture and market generic versions of Rexulti. These generic alternatives must demonstrate bioequivalence to the brand-name drug, meaning they deliver the same amount of active ingredient into the bloodstream in the same amount of time [2]. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA), review these applications to ensure safety and efficacy [2].
What Are the Patents Protecting Rexulti?
Rexulti is protected by several patents related to its composition and methods of use. The key patent for the drug is expected to expire in 2027 [1].
Can Generics Enter Before the Patent Expires?
In some cases, generic manufacturers may challenge existing patents, potentially leading to earlier market entry. The outcome of such legal challenges can significantly alter the timeline for generic availability. Information on patent challenges and their status can often be found on resources like DrugPatentWatch.com [3].
How Does Rexulti Work?
Rexulti is an atypical antipsychotic used to treat schizophrenia and as an adjunctive treatment for major depressive disorder [4]. It works by modulating the activity of certain neurotransmitters in the brain, primarily dopamine and serotonin [4].
What Are the Alternatives to Rexulti?
For schizophrenia, other atypical antipsychotics are available, including aripiprazole (Abilify), quetiapine (Seroquel), and ziprasidone (Geodon) [5]. In the case of adjunctive treatment for major depressive disorder, other options may include different antidepressant medications or augmentation strategies [6].
What Is the Price of Rexulti?
The cost of Rexulti can vary significantly based on insurance coverage, pharmacy, and dosage [7]. Without insurance, the price can be substantial, but patient assistance programs and the eventual availability of generics are factors that can influence out-of-pocket expenses [7].
Who Manufactures Rexulti?
Rexulti is manufactured by Otsuka Pharmaceutical Co., Ltd. [8].
---
Sources:
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration. (n.d.). Generic Drugs: Questions and Answers.
3. DrugPatentWatch.com
4. Otsuka Pharmaceutical Co., Ltd. (n.d.). Rexulti® (brexpiprazole) prescribing information.
5. National Institute of Mental Health. (n.d.). Schizophrenia.
6. National Institute of Mental Health. (n.d.). Depression.
7. GoodRx. (n.d.). Rexulti Prices, Coupons, and Patient Assistance Programs.
8. Otsuka Pharmaceutical Co., Ltd. (n.d.). Otsuka Pharmaceutical Announces Positive Results from Phase 3 Studies of Brexpiprazole in Japan.